We employed an orthotopic xenograft model of pancreatic ductal adenocarcinoma to examine in vivo targeting of mutp53-ENTPD5-mediated ITGA5 regulation for cancer therapy. Here, ENTPD5 is linked to pancreatic ductal adenocarcinoma.